NCT00307671
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, Autoimmune Diseases, +25 more
- Locations
-
- Hôpital Cochin Paris, France
Clinical trial condition
Churg-Strauss Syndrome
Explore clinical trials studying Churg-Strauss Syndrome. Study availability and eligibility vary by location and protocol.
48 public trials
11 recruiting studies
Churg-Strauss Syndrome trial results
NCT00307593
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +27 more
- Locations
-
- Hôpital Cochin Paris, France
Active, Not Recruiting
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Gainesville, Florida, United States
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site New York, United States
Active, Not Recruiting
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
- Mayo Clinic Rochester, Minnesota, United States
- Cleveland Clinic Cleveland, Ohio, United States
- The Ohio State University Wexner Medical Center Columbus, Ohio, United States
Active, Not Recruiting
Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
NCT04157348
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- Research Site Denver, Colorado, United States
- Research Site Ann Arbor, Michigan, United States
- Research Site Rochester, Minnesota, United States
- Research Site Albuquerque, New Mexico, United States
Active, Not Recruiting
Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
NCT06230354
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- Aberdeen Royal Infirmary - NHS Grampian Aberdeen, United Kingdom
- University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
- Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
- Royal Infirmary of Edinburgh - NHS Lothian Edinburgh, United Kingdom
Active, Not Recruiting
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
NCT05030155
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- Service de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques "Hôpital Cochin Paris, France
Active, Not Recruiting
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
NCT05732402
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
- Locations
-
- Investigational Site (523) Phoenix, Arizona, United States
- Investigational Site (501) Phoenix, Arizona, United States
- Investigational Site (524) Tucson, Arizona, United States
- Investigational Site (506) Valencia, California, United States